The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder

被引：0
|
作者：
Tice, Jeffrey A. [1 ]
Whittington, Melanie D. [2 ]
Campbell, Jonathan D. [2 ]
Pearson, Steven D. [2 ]
机构：
[1] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Inst Clin & Econ Review, Boston, MA USA
来源：
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 2021年 / 27卷 / 04期
关键词：
BUPRENORPHINE/NALOXONE;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：528 / 532
页数：5
相关论文
共 50 条
  • [41] Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
    van Reekum, Emma A.
    Rosic, Tea
    Hudson, Jacqueline
    Sanger, Nitika
    Marsh, David C.
    Worster, Andrew
    Thabane, Lehana
    Samaan, Zainab
    [J]. BIOLOGY OF SEX DIFFERENCES, 2020, 11 (01)
  • [42] Trends in receipt of medication-assisted treatment for pregnant women with opioid use disorder in the United States
    MacAfee, Lauren
    Sawyer, Anne
    Terplan, Mishka
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E125 - E125
  • [43] Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
    Cantone, Rebecca E.
    Garvey, Brian
    O'Neill, Allison
    Fleishman, Joan
    Cohen, Deborah
    Muench, John
    Bailey, Steffani R.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2019, 32 (05) : 724 - 731
  • [44] Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder
    Phillips, Reid H.
    Salzman, Matthew
    Haroz, Rachel
    Rafeq, Rachel
    Mazzarelli, Anthony J.
    Pelletier-Bui, Alexis
    [J]. ANNALS OF EMERGENCY MEDICINE, 2019, 74 (03) : 430 - 432
  • [45] Opioid Use Disorders, Medication-Assisted Treatment, and the Role of the Laboratory
    Bertholf, Roger L.
    Reisfield, Gary M.
    [J]. LABORATORY MEDICINE, 2017, 48 (04) : E57 - E61
  • [46] Personal and Socioeconomic Determinants in Medication-assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults
    Grubb, Laura K.
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (09) : 1669 - 1680
  • [47] Medication-Assisted Treatment for Opioid Use Disorder (OUD): Solving the Puzzle With Clinical Pharmacist Providers
    Wells, Ian
    [J]. JOURNAL OF PHARMACY PRACTICE, 2020, 33 (02) : 124 - 124
  • [48] Implementation of hepatitis C screening within a pharmacist-managed medication-assisted therapy opioid use disorder protocol program
    Llayton, Chelsey K.
    Harlow, Christopher P.
    Burris, Julie N.
    Rhodes, Jill
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (06) : E307 - E311
  • [49] INDIVIDUALS RECEIVING METHADONE FOR MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER SHOW EVIDENCE OF RESPIRATORY DEPRESSION
    Finlay, M.
    Wilson, M.
    Erwin, J. A.
    Hansen, D. A.
    Layton, M. E.
    Quock, R. M.
    Van Dongen, H.
    [J]. SLEEP, 2020, 43 : A278 - A278
  • [50] Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans
    Kirby, Taylor
    Connell, Robert
    Linneman, Travis
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (04) : 301 - 309
12345